A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults-Reference-Cited by-同舟云学术

A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults

Published:2023-05 Issue:22 Volume:41 Page:3454-3460
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Vanni Tazio,da Graça Salomão Maria,Viscondi Juliana Yukari Kodaira,Braga Patrícia Emilia,da Silva Anderson,de Oliveira Piorelli Roberta,do Prado Santos Joane,Gattás Vera Lúcia,Lucchesi Maria Beatriz Bastos,de Oliveira Mayra Martho Moura,Koike Marcelo Eiji,Campos Lucia M.A.,Coelho Eduardo B.,Weckx Lily Yin,Lara Amanda Nazareth,Paiva Terezinha M.,Timenetsky Maria do Carmo S.T.,Precioso Alexander Roberto

Funder

Fundação Butantan

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference21 articles.

1. A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries;Haugh;Expert Rev Vaccines,2017

2. Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America;Jamotte;Hum Vaccin Immunother,2017

3. influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems;Precioso;Vaccine,2011

4. Mondini G, Braga PE, Lopes MH, et al. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan. Rev Inst Med Trop Sao Paulo. 2018; 60: e37. Published 2018 Jul 30. doi:10.1590/S1678-9946201860037.

5. Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan;Koike;Vaccine,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02